KRYS compared with ARWR: revenue, margins and what each company keeps, and the suppliers and customers both name

KRYSKrystal Biotech, Inc.

Mkt capRevenueRevenue

ARWRArrowhead Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KRYS 2

—Hospitals and specialty distributorsunlistedcustomer

—Specialty pharmacy providersunlistedcustomer

Shared 0

No shared counterparties.

Only ARWR 4

AMGNAmgencustomer

SRPTSarepta Therapeuticscustomer

NVSNovartis Pharmacustomer

—Takeda Pharmaceuticalunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

customer

KRYSKrystal Biotech, Inc.

295.30· pre 295.27· delayed

Mkt cap$8.8BRevenue$127MQ3 FY26Revenue$389MFY25

ARWRArrowhead Pharmaceuticals, Inc.

60.68· pre 59.68· delayed

Pre-marketNov 2 '26delayed

Mkt cap$8.5BRevenue$75MQ3 FY26Revenue$829MFY25

Compare

Pre-marketNov 2 '26delayed

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

295.30pre 295.27delayed

Price

60.68pre 59.68delayed

$8.8B

Mkt cap

$8.5B

Q3 FY26$127M

Revenue

$75MQ3 FY26

FY25$389M

Revenue

$829MFY25

KRYS295.30vsARWR60.68Pre-marketNov 2 '26delayed